bioMérieux Recognized as Top 1% by S&P Global
March 27, 2025
bioMérieux is honored to be recognized in the top 1% of the S&P Global Sustainability Yearbook 2025, achieving a score of 70/100 in the Health Care Equipment & Supply segment. Out of 7,690 assessed companies across 62 industries, only 780 top performers have received this distinction, highlighting their excellence in sustainable business practices.
Furthermore, bioMérieux was ranked 1st in the sector of healthcare equipment and Supply by the Dow Jones Sustainability Index (DJSI) through the S&P Global Corporate Sustainability Assessment. bioMérieux first joined the DJSI in 2021 and has proudly risen to the top position in just four years! This recognition underscores the company’s strong commitment to Corporate Social Responsibility, reinforcing its mission to create a positive impact worldwide while preserving the planet as a healthy place to live.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
